A Potential Shift In Enforcement Priorities For The FTC

Cyber Defense Magazine

July 2017
Reprinted with permission.

During the course of a long-running data security action against a medical testing laboratory, the Federal Trade Commission (FTC) has been steadfast in its position that legally actionable harm to consumers exists even where there is no evidence of actual harm. Although it is probably too late for that particular company, it appears that the FTC’s position may be shifting.

Read Julie O'Neill's piece in Cyber Defense Magazine.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.